Trellus Health plc (FRA:85Q)

Germany flag Germany · Delayed Price · Currency is EUR
0.0045
-0.0005 (-10.00%)
At close: Nov 27, 2025
800.00%
Market Cap1.01M
Revenue (ttm)305.69K
Net Income (ttm)-5.87M
Shares Outn/a
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0045
Previous Close0.0050
Day's Range0.0045 - 0.0045
52-Week Range0.0005 - 0.0560
Betan/a
RSI45.40
Earnings DateDec 9, 2025

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a proprietary HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease (IBD), including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York. [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 2020
Employees 18
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 85Q
Full Company Profile

Financial Performance

In 2024, Trellus Health's revenue was $114,000, an increase of 500.00% compared to the previous year's $19,000. Losses were -$7.78 million, 22.8% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.